All News #Library
Rare Diseases
Arcturus Reports Positive Ph 2 Data in OTC Deficiency
30 Jun 2025 //
BUSINESSWIRE
Arcturus Therapeutic to Host KOL Presentation on ARCT-810 Phase 2
23 Jun 2025 //
BUSINESSWIRE
Arcturus Receives Orphan Medicinal Product Designation from the EC for ARCT-032
22 Feb 2024 //
BUSINESSWIRE
Arcturus Receives Orphan Drug Designation from FDA for ARCT-032
27 Nov 2023 //
BUSINESSWIRE

Market Place
Sourcing Support